Delivery Order SPE2DB22D1055-SPE2DB25FSGD7
Award Date
4/3/25
Potential Completion Date
4/4/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,735.80 Firm Fixed Price Delivery Order is for the supply of 4567520460 - Cyclophosphamide 500 mg Vials, with a period of performance through March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Cyclophosphamide 500 mg vials, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,219.04 and an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
This federal contract award is a delivery order, valued at $14,682.20, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,567,254,079 vials of the drug Cyclophosphamide, at 2 grams per vial. The contract has a firm-fixed price pricing type and a period of performance running through February 13, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to the Defense Logistics Agency (DLA). The $9,120.41 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 9, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to support healthcare programs administered by the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with a ceiling value of $10,761.60 and a completion date of September 1, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.60 firm fixed-price delivery order is for the supply of 4,567,115,988 units of 50 mg Cyclophosphamide capsules. The contract has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. This award is associated with a larger DLA Troop Support Medical Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FY2UA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567822313 CYCLOPHOSPHAMIDE 1 GM VIALS, a critical medical commodity. The award has a ceiling value of $1,130.96 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of April 8, 2025. This contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a medication used in the treatment of various medical conditions. The contract has a ceiling value of $3,886.98 and a period of performance through April 18, 2025. This award is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This federal contract award, valued at $1,052.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award, valued at $53,317.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical...